Statera BioPharma (STU:7CB) Long-Term Debt : €0.00 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma Long-Term Debt?

Statera BioPharma's Long-Term Debt for the quarter that ended in Sep. 2022 was €0.00 Mil.

Statera BioPharma's annual Long-Term Debt stayed the same from Dec. 2019 (€0.00 Mil) to Dec. 2020 (€0.00 Mil) but then increased from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€9.40 Mil).

Statera BioPharma Long-Term Debt Historical Data

The historical data trend for Statera BioPharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma Long-Term Debt Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

Long-Term Debt

9.40

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Long-Term Debt	Get a 7-Day Free Trial						10.98	9.40	-	-	-

Statera BioPharma (STU:7CB) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Statera BioPharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines